Table 3 QLQ – C30 & BR – 23 adjusted scale scores*
Variables | N | Mean (SE) | 95% C.I. |
|---|---|---|---|
QLQ C-30 functional scales | |||
Global QOL/general health | 331 | 45.0(0.8) | 43.4 – 46.7 |
Physical functioning | 316 | 52.7(1.1) | 50.6 – 54.8 |
Role functioning | 331 | 55.1(1.2) | 52.7 – 57.4 |
Emotional | 314 | 60.2(1.8) | 57.7 – 62.7 |
Cognitive | 333 | 59.4(1.3) | 57.3 – 62.5 |
Social | 330 | 61.3(1.3) | 58.9 – 63.8 |
QLQ C – 30 symptoms scales | |||
Fatigue | 322 | 38.9(1.2) | 36.5 – 41.2 |
Nausea & vomiting | 326 | 30.2(1.3) | 27.5 – 32.8 |
Pain | 325 | 43.8(1.2) | 41.4 – 46.2 |
Dyspnoea | 327 | 42.1(1.5) | 39.1 – 45.1 |
Sleep disturbance | 329 | 42.7(1.6) | 39.5 – 45.6 |
Appetite loss | 330 | 37.4(1.5) | 34.4 – 40.4 |
Constipation | 336 | 27.8(1.5) | 24.8 – 30.8 |
Diarrhea | 334 | 21.9(1.5) | 19.0 – 24.9 |
Financial impact | 335 | 31.2(1.4) | 28.5 – 33.9 |
QOL – BR23: functional scales | |||
Body image | 290 | 61.8(1.4) | 59.2 – 64.5 |
Sexual functioning | 295 | 70.2(1.3) | 67.6 – 72.9 |
Sexual enjoyment | 215 | 61.8(1.6) | 58.7 – 64.9 |
Future perspective | 325 | 59.7(1.8) | 56.3 – 63.1 |
QLQ – BR23: Symptom scales | |||
Systemic side effects | 292 | 40.2(1.0) | 38.2 – 42.2 |
Breast symptoms | 284 | 35.3(1.5) | 32.4 – 38.3 |
Arm symptoms | 309 | 38.2(1.3) | 35.6 – 40.8 |
Upset by hair loss | 323 | 44.4(1.6) | 41.2 – 47.6 |